ProfileGDS5068 / 1555181_a_at
TitleRheumatoid arthritic synovium response to tocilizumab
OrganismHomo sapiens


baseline tocilizumab patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 GSM1116933 GSM1116935 GSM1116937 GSM1116939 GSM1116941 GSM1116943 GSM1116945 GSM1116947 GSM1116949 GSM1116951 GSM1116953 GSM1116955 GSM1116934 GSM1116936 GSM1116938 GSM1116940 GSM1116942 GSM1116944 GSM1116946 GSM1116948 GSM1116950 GSM1116952 GSM1116954 GSM1116956 25% 77% 96% 34% 20% 82% 79% 23% 44% 22% 56% 46% 60% 70% 61% 56% 27% 36% 54% 65% 34% 38% 72% 49% sort by agent sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1116933Synovial tissue prior to Tocilizumab therapy, repl 1-0.16427625
GSM1116935Synovial tissue prior to Tocilizumab therapy, repl 20.14059477
GSM1116937Synovial tissue prior to Tocilizumab therapy, repl 30.42262696
GSM1116939Synovial tissue prior to Tocilizumab therapy, repl 4-0.060044334
GSM1116941Synovial tissue prior to Tocilizumab therapy, repl 5-0.12725320
GSM1116943Synovial tissue prior to Tocilizumab therapy, repl 60.17995582
GSM1116945Synovial tissue prior to Tocilizumab therapy, repl 70.2079479
GSM1116947Synovial tissue prior to Tocilizumab therapy, repl 8-0.14780223
GSM1116949Synovial tissue prior to Tocilizumab therapy, repl 9-0.031737344
GSM1116951Synovial tissue prior to Tocilizumab therapy, repl 10-0.14742922
GSM1116953Synovial tissue prior to Tocilizumab therapy, repl 110.025997256
GSM1116955Synovial tissue prior to Tocilizumab therapy, repl 12-0.0080156346
GSM1116934Synovial tissue after to Tocilizumab therapy, repl 10.031973860
GSM1116936Synovial tissue after to Tocilizumab therapy, repl 20.1282870
GSM1116938Synovial tissue after to Tocilizumab therapy, repl 30.025730161
GSM1116940Synovial tissue after to Tocilizumab therapy, repl 40.072399156
GSM1116942Synovial tissue after to Tocilizumab therapy, repl 5-0.12242727
GSM1116944Synovial tissue after to Tocilizumab therapy, repl 6-0.044190436
GSM1116946Synovial tissue after to Tocilizumab therapy, repl 7-0.00056854
GSM1116948Synovial tissue after to Tocilizumab therapy, repl 80.064036465
GSM1116950Synovial tissue after to Tocilizumab therapy, repl 9-0.082642634
GSM1116952Synovial tissue after to Tocilizumab therapy, repl 10-0.0467338
GSM1116954Synovial tissue after to Tocilizumab therapy, repl 110.095665972
GSM1116956Synovial tissue after to Tocilizumab therapy, repl 12-0.0019607549